Cigarette smoking and disease activity, organ damage, and cutaneous manifestations in systemic lupus erythematosus: a systematic review
Annals of Middle Eastern Medicine · 18.08.2026 · 2 (3) · 281-289
DOI: 10.24911/amem.15-2868 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Annals of Middle Eastern Medicine, online erschienen am 15.08.2026. Verfasst von Nermeen A Awad und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Smoking may modify systemic lupus erythematosus (SLE) activity, damage, and phenotype. This review aims to summarize associations between smoking exposure and SLE outcomes.
Methods
Systematic review of primary studies assessing smoking in SLE and reporting clinical or biomarker outcomes. Five eligible studies (2002–2021) were included (total N=1,079). Participants were predominantly female (87–96.2%); where reported, most were Caucasian (73.7–92%) with mean/median age 37–49 years and disease duration ~9–13.5 years. Smoking exposure definitions varied substantially, limiting direct quantitative pooling and precluding meta-analysis across studies.
Results
Ever-smoking prevalence ranged ~37–51%. In one observational study, current smokers had higher disease activity than never smokers (mean total SLEDAI 15.63±1.63 vs 9.03±0.99; p=0.0024) and a dose–response by packs/day (p=0.001). In a retrospective cohort, never exposure to active or second-hand smoke reduced risk of damage accrual (SDI>0: RR 0.78, 95% CI 0.62–0.97; p=0.0228). Heavy smoking (>20 pack-years) was associated with discoid rash (OR 2.22), photosensitivity (OR 2.19) and neurological disorder (OR 3.16), but inversely associated with renal disorder (OR 0.40), non-erosive arthritis (OR 0.45) and haematological disorder (OR 0.40). Current smoking increased cutaneous damage (any OR 2.73; scarring OR 4.70; active rash OR 6.18). IL-17A levels were similar in SLE and controls, did not correlate with SLEDAI-2K or SDI, and inversely correlated with years of smoking (Rs≈−0.43; p≈0.001). Another study reported no significant differences in cumulative damage scores across smoking categories.
Conclusion
Evidence from five heterogeneous studies links smoking with higher SLE activity and cutaneous damage and suggests phenotype-specific associations. Standardized exposure measures and prospective designs are needed.
Zitieren
APA
Awad, N. A., Baghlaf, L. B., Alsulami, R. A., Alotaibi, S., Alshehabi, S. K., & Madhi, W. S. B. (2026). Cigarette smoking and disease activity, organ damage, and cutaneous manifestations in systemic lupus erythematosus: a systematic review. Annals of Middle Eastern Medicine, 2(3), 281-289. https://doi.org/10.24911/amem.15-2868
Vancouver
Awad NA, Baghlaf LB, Alsulami RA, Alotaibi S, Alshehabi SK, Madhi WSB. Cigarette smoking and disease activity, organ damage, and cutaneous manifestations in systemic lupus erythematosus: a systematic review. Annals of Middle Eastern Medicine. 2026;2(3):281-289. doi:10.24911/amem.15-2868
BibTeX
@article{Awad2026,
author = {Awad, Nermeen A and Baghlaf, Lujain B and Alsulami, Rasha A and Alotaibi, Samah and Alshehabi, Sarah K and Madhi, Wed S Bin},
title = {Cigarette smoking and disease activity, organ damage, and cutaneous manifestations in systemic lupus erythematosus: a systematic review},
journal = {Annals of Middle Eastern Medicine},
year = {2026},
volume = {2},
number = {3},
pages = {281--289},
doi = {10.24911/amem.15-2868}
}
EUVIMED